Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alpha Biologics To Manufacture for Synairgen | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Alpha Biologics To Manufacture for Synairgen

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Synairgen, a company developing novel therapies for asthma and COPD, has selected Alpha Biologics to help with the advancement of its growth factor drug development program. Alpha will develop a scaleable manufacturing process for Synairgen’s optimized growth factor to support preclinical and clinical development. Richard Marsden, Synairgen’s managing director, said, “We have significant confidence in our growth factor drug development program for asthma to restore barrier function in patients. Initiating the development of a scaleable manufacturing process is another significant milestone for the program.”

Cambridge, UK-based Alpha Biologics is an independent contract biomanufacturing organisation offering FDA/EMEA cGMP compliant services to the worldwide pharmaceutical and biotechnology industry.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics